SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes
Wendy Wang, Lin Y. Chen, Rob F. Walker, Lisa S. Chow, Faye L. Norby, Álvaro Alonso, James S. Pankow, Pamela L. Lutsey
Topics & Concepts
MedicineType 2 diabetesDiabetes mellitusDiseaseInternal medicineIntensive care medicineEndocrinologyDiabetes Treatment and ManagementPancreatic function and diabetesHeart Failure Treatment and Management